PF-2341066 (Crizotinib)
Important Notice: For research use only. We do not sell to patients.
Other Forms of PF-2341066 (Crizotinib)
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | PF-2341066 (Crizotinib) is an inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM). | ||
---|---|---|---|
Targets |
|
Catalog Num | A10712 |
---|---|
Formula | C21H22Cl2FN5O |
Molecular Weight | 450.3 |
CAS Number | 877399-52-5 |
SMILES | C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 8 mg/mL (17.76 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+30% PEG 300+dd H2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.21 mL | 111.04 mL | 222.07 mL |
0.5 mM | 4.44 mL | 22.21 mL | 44.41 mL |
1 mM | 2.22 mL | 11.1 mL | 22.21 mL |
5 mM | 0.44 mL | 2.22 mL | 4.44 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2